Abstract
Background:
For pregnant women who require an emergency cesarean section (CS), extending labor epidural analgesia as quickly as feasible to good quality anesthesia is a critical issue. This indicates the presence of functional labor epidural analgesia and reduces the need for general anesthesia. Addition of magnesium increases anesthetic and analgesic qualities of epidural anesthesia.Objectives:
The purpose of this trial was to assess the role of adding magnesium sulfate (MgSO4) with levobupivacaine to speed up the conversion of labor epidural analgesia into enough anesthesia for emergency CS.Methods:
Fifty parturients were randomly assigned to receive 19.5 mL of levobupivacaine 0.5% with either 0.5 mL of normal saline 0.9% (Group I) or 0.5 mL of MgSO4 10% (Group II) after receiving labor epidural analgesia. We documented the onset of block (loss of pinprick to T6), number of patients needing additional analgesia, the time needed for sensory and motor blockade to recover, and the adverse effects.Results:
The frequency of patients receiving intraoperative supplements was comparable in the study groups (P = 0.491), although the onset of the block was faster in Group II than in Group I (P = 0.000*). Group II took substantially longer to recover from sensory and motor blockade than Group I (P = 0.001* and P = 0.001*, respectively). In both groups, the occurrence of adverse events was similar.Conclusions:
Adding 50 mg of MgSO4 to levobupivacaine 0.5% accelerated the epidural top, and both sensory onset and motor blocks period were prolonged as compared to levobupivacaine alone when extending epidural analgesia for emergency CS.Keywords
Anesthesia Cesarean Section Epidural Levobupivacaine Magnesium Sulfate Obstetric
1. Background
Among the various methods used to relief labor pain, the best one is the neuraxial analgesia (1-3). Epidural technique is a popular efficient approach for delivering adequate pain relief during delivery (4). The epidural catheter can be used to extend an existing block and deliver anesthetic for an emergency cesarean section (CS). Successful conversion is an important indicator of quality and safety since it indicates the presence of functional epidural analgesia and reduces the need for general anesthesia (GA) (5), as well as GA-related side effects (6).
For this purpose, various local anesthetics (LAs) have been used, and the optimal one aimed for a quick onset and good quality of epidural anesthesia (EA) (7). There have been several trials examining the efficacy of different LAs and adjuncts, but none has clarified the optimal solution (8).
Bupivacaine, alone or with different adjuvants, is the most common drug used for CS, and it has a deep and prolonged sensory block (9). Because levobupivacaine is a pure levo-isomer, it has a lower cardiac or neurotoxic effect than racemic bupivacaine. This is crucial when administering high dosages of LA to prolong epidural block to minimize systemic toxicity from inadvertent intrathecal or intravascular administration (10).
Magnesium has analgesic characteristics, which are principally connected to calcium influx modulation and action as a voltage gated antagonist of N-methyl-D-aspartate (NMDA) receptors involved in pain transmission (11-13). Many studies conducted on obstetric anesthesia have searched the efficacy of magnesium sulfate (MgSO4) when combined with spinal anesthesia (14), added to spinal-EA (15, 16). According to these investigations, it increases anesthetic and analgesic qualities while causing no additional side effects, mainly hypotension, which is the most common side effect in spinal anesthesia (17-20).
2. Objectives
This study aimed to detect if using MgSO4 with levobupivacaine could help to speed up the onset of the block while extending pre-existing labor epidural analgesia to enable EA for emergency CS.
3. Methods
This prospective double-blind randomized controlled trial was conducted from August 2020 to June 2021 at Tanta university hospitals in Egypt. The trial was registered at Pan African Clinical Trials after approval of the Institutional Ethics Committee (No:33929/7/20; Tanta University, Faculty of Medicine) (PACTR202007634121137, principal investigator: Radwa Fathy Mansour.; date of approval: July 30, 2020). All participants signed an informed written permission form before starting labor analgesia.
The study included parturients who were in active labor (gestational age > 37 weeks), aged 18 - 35 years, had an American Society of Anesthesiologists physical status II, and admitted for an emergency CS after an established labor EA, and a good fetal condition. Patients were excluded if they had an emergency CS of the first type, multiple pregnancies, a high-risk pregnancy (e.g. preeclampsia, antepartum hemorrhage, diabetes mellitus, body mass index (BMI) ≥ 35 kg/m2), a malfunctioning epidural catheter during the labor (no analgesia after two intra-partum top-up doses), last labor epidural supplementation of less than two hours, hemodynamic instability after a previous top-up, or documented history of allergy to any of the drugs used in the trial.
All participants received a low-dose EA regimen that included a bolus dose of 1 mL fentanyl (50 µg) mixed to 9 mL 0.125% levobupivacaine and a subsequent infusion of levobupivacaine 0.125% with fentanyl (2 µg/mL) at a rate of 10 mL/h. To obtain the desired degree of labor analgesia, an extra supplementation of 5 mL levobupivacaine 0.125% bolus was given if necessary (up to T10).
Parturients were moved to the operating room, and standard monitoring such as electrocardiography, pulse oximetry, and non-invasive blood pressure were used once the choice for emergency CS was reached.
The patients were randomly allocated into two equal groups of 25 patients each at a ratio of 1:1 to receive 19.5 mL of levobupivacaine 0.5% with either 0.5 mL of normal saline 0.9% (Group I) or 0.5 mL of MgSO4 10% equivalent to 50 mg (Group II) using computer-generated randomization numbers enclosed in sealed opaque envelopes. To ensure blinding, the anesthetic mixtures were prepared in two identical syringes labeled as syringes 1 and 2 by an anesthesiologist who had no further involvement in the study, while injection of the top-up epidural anesthetic doses and recording of outcomes were done by a different investigator who was unaware of group allocation. The LA was then given in aliquots over three minutes through the epidural catheter following negative aspiration; then, the established levels of sensory and motor blocks were tested (0 = can raise extended leg off bed; 1 = can bend knees; 2 = can bend ankles; 3 = unable to bend knees or ankles).
The interval between the completion of the epidural top-up injections and verification of the block to pinprick perception up to the T6 dermatome is described as the onset of block (our primary outcome). Testing for the level of blockade was performed at 3-minute intervals; if inadequate anesthesia was reported after 20 minutes, a supplementary top-up dose of 5 mL of lidocaine 2% was given and reassessment was done 10 minutes later. Absence of adequate T6 sensory block after 30 minutes was considered as block failure warranting the conversion to general anesthesia, and the patient was withdrawn from the study.
During surgery, further epidural increments (5 mL of lidocaine 2%) were supplied if breakthrough pain was indicated by a visual analogue scale (VAS) > 3 or if any patient’s discomfort was experienced, and the number of patients who required supplemental analgesia was documented. Sedation levels were also measured every 10 minutes on a four-point scale (1 = Awake and attentive, 2 = Drowsy, responsive to verbal stimuli, 3 = Drowsy, arousable to physical stimuli, 4 = Unarousable).
Hypotensive episodes were treated with an intravenous (IV) fluid bolus and ephedrine 5 mg increments. Atropine 0.5 mg IV bolus was used to treat bradycardia. Patients were monitored for 24 hours postoperatively. The initial onset of analgesic request and a Bromage score of 0 were used to identify sensory and motor block recovery. The time from administering the study medications until recovery was assessed and recorded by a trained nurse every 30 minutes. In addition, the incidence of adverse events 24 hours postoperatively (e.g., nausea, vomiting, and sedation level ≥ 2) was recorded.
3.1. Statistical Analysis
The onset of the sensory blackout was our primary outcome variable. According to prior research, the mean ± standard deviation (SD) time to start the sensory block of epidural levobupivacaine in extending labor analgesia for emergency CS was 155.83 minutes (8, 21). The sample size calculation found that each group needed a minimum of 23 patients to detect a clinically significant onset time difference of 5 minutes between groups at an error rate of 0.05 and an 80% power of the study. Assuming a 10% dropout rate, each group included 25 members. For statistical analysis, the statistical software Minitab® 16 (Minitab, Inc, LLC, State College, Pennsylvania) was used. The Kolmogorov-Smirnov test was used to ensure that the data was normal. Numerical data was compared between the two groups using Student’s independent t-test for data with normal distribution or Mann–Whitney U test if the data did not have normal distribution. Patients’ numbers and percentages (%) were used to express categorical variables, which were compared using the chi-square test or Fisher’s exact test when suitable. Significance was defined as P < 0.05.
4. Results
In total, we included 93 eligible parturients in this study. Seventeen patients did not comply with our inclusion criteria (nine patients were preeclampsia, four patients had their last epidural top-ups less than 2 h, three patients had BMI ≥ 35, and one patient was grade 1 emergency cesarean delivery), and 26 patients declined to take part in the research. Fifty patients were enlisted and evenly distributed across the study groups. Two of the patients in group I and three of the patients in group II did not reach the T6 sensory level, and were excluded from analysis (Figure 1).
Contrast flow diagram of participants through each stage of the randomized trial.
The demographic features of the studied participants, as well as the indications and duration of CS, did not differ between the two groups (Table 1). Both groups were also similar regarding the details of the already established EA (Table 2).
Demographic Characteristics and Duration of Surgery in the Studied Parturients a
| Variables | Group I (n = 23) | Group II (n = 22) | P-Value b |
|---|---|---|---|
| Age (y) | 27.39 ± 3.83 | 28.18 ± 4.02 | 0.504 |
| BMI (kg/m2) | 28.01 ± 3.29 | 27.12 ± 3.71 | 0.400 |
| Gestational age (weeks) | 38.87 ± 1.06 | 38.500 ± 0.913 | 0.216 |
| Parity; nulliparous/multiparous | 4 (17.4)/19 (82.6) | 5 (22.7)/17 (77.3) | 0.722 |
| Duration of surgery (min) | 38.65 ± 6.87 | 40 ± 7.33 | 0.528 |
| Variables | Group I (n = 23) | Group II (n = 22) | P-Value c |
|---|---|---|---|
| Duration of labor analgesia (h) | 6.83 ± 1.40 | 6.64 ± 1.62 | 0.677 |
| Time since last top-up dose (min) | 189.8 ± 44.6 | 200.0 ± 46.1 | 0.454 |
| Pre-sensory level (%) | 0.725 | ||
| T7 | 1 | 0 | |
| T8 | 3 | 3 | |
| T9 | 2 | 3 | |
| T10 | 5 | 5 | |
| T11 | 3 | 6 | |
| T12 | 3 | 3 | |
| L1 | 5 | 2 | |
| L2 | 1 | 0 | |
| Pre-motor level | 0 (0 - 1) | 1 (0 - 1) | 0.665 |
| Pre –VAS | 2 (2 - 3) | 2.5 (2 - 3) | 0.785 |
In comparison to Group I, the time necessary to block the pinprick sensation up to T6 was significantly shorter in Group II (P = 0.000*). Furthermore, the sensory block level and the degree of motor blockade at the start of surgery were comparable in both groups (P = 0.636 and P = 0.384, respectively). In terms of the number of patients getting intra-operative supplements or the neonatal Apgar scoring, no significant differences were detected between the groups (P = 0.794, 0.491, 0.812 at 1 min, and 0.681 at 5 min, respectively). Nevertheless, Group II experienced a considerably longer duration of analgesia than group I, as well as a longer period for motor block regression to a Bromage score of 0 (P = 0.001* for all) (Table 3).
Operative Data and Adverse Events
| Variables | Group I (n = 23) a | Group II (n = 22) a | P-Value |
|---|---|---|---|
| Time to block at level T6 (min) | 19.17 ± 4.46 | 13.82 ± 3.39 | 0.000 b |
| Number of patients who needed top-up to reach level T6, No. (%) | 6 (26.08) | 1 (4.55) | 0.096 |
| Sensory level at the start of surgery (%) | 0.636 | ||
| T1 | 0 | 1 | |
| T2 | 2 | 5 | |
| T3 | 5 | 5 | |
| T4 | 7 | 4 | |
| T5 | 7 | 5 | |
| T6 | 2 | 2 | |
| Motor block at the start of surgery | 2 (2 - 3) R: 1 - 3 | 3 (2 - 3) R: 1 - 3 | 0.384 |
| Number of patients needing supplemental intra-operative analgesia (%) | 7 | 4 | 0.491 |
| Duration of analgesia (min) | 130.83 ± 27.66 | 160.77 ± 26.4 | 0.001 b |
| Time to motor recovery (min) | 119.05 ± 7.67 | 126.09 ± 5.74 | 0.001 b |
| Apgar score | |||
| 1 min | 9 (9 - 10) | 9 (9 - 10) | 0.812 |
| 5 min | 10 (10 - 10) | 10 (9 - 10) | 0.681 |
| Adverse events (%) | |||
| Hypotension | 6 (26.1) | 8 (36.4) | 0.530 |
| Bradycardia | 2 (8.7) | 3 (13.6) | 0.665 |
| Nausea | 7 (30.4) | 5 (22.7) | 0.738 |
| Vomiting | 5 (21.7) | 3 (13.6) | 0.699 |
| Sedation ≥ 2 | 0 (0) | 0 (0) | - |
The two groups had equal rates of adverse events such as hypotension, vomiting, bradycardia, and nausea. There were no patients in either group with a sedation level of ≥ 2 (Table 3).
5. Discussion
During the management of emergency CS, short time from decision of delivery to induction of anesthesia can influence the mode of anesthesia. Although spinal anesthesia is popular in this situation, EA should be utilized if labor analgesia is established prior to an emergency CS.
In our study, during the conversion of EA to surgical anesthesia for emergency CS, the addition of MgSO4 (50 mg) to epidural levobupivacaine 0.5% was investigated. The addition of MgSO4 as an adjuvant provided a sensory block with a rapid onset and a lengthy duration, and it extended the duration of the motor block. In addition, it reduced the number of patients who needed supplemental dose of anesthesia intra-operatively. We also considered the consequences of adding MgSO4; there were no harms to the newborn, and no differences were observed in terms of maternal adverse effects.
The dose of MgSO4 in this study was based on a study by Ghatak et al. (22), demonstrating that adding 50 mg of MgSO4 to epidural bupivacaine resulted in rapid onset of anesthesia without complications.
The findings of our investigation are comparable to those by Hasanein et al. (16), reporting that adding MgSO4 to epidural bupivacaine and fentanyl for labor analgesia reduced the breakthrough pain and had a longer duration of action.
Also, our findings are in line with those of Elsharkawy et al. (23), reporting that adding MgSO4 to EA (in elective CS) had fast onset and prolonged duration of action with improved analgesic profile. Although they used higher dose of MgSO4 (500 mg) than our study, there were no neonatal or maternal complications. Ko et al. (24) demonstrated that large intravenous dose of MgSO4 did not increase its concentration in cerebrospinal fluid and had no postoperative analgesic effect. Also, Sun et al. (25) showed that a bolus dosage of magnesium (500 mg) administered via epidural injection produced a spinally mediated analgesic effect with no systemic adverse effects (26).
Irrespective of the type of surgery, some previous studies (27-30) demonstrated that addition of magnesium to bupivacaine and/or opioid resulted in accelerating the onset of sensory block. Moreover, some other studies (27, 28) showed that the addition of magnesium to levobupivacaine hastened the onset of motor block, prolonged the duration of motor and sensory block, and had no major side effects. In contrast to our results, Ahmed et al. (29) found that magnesium showed more incidence of pain with injection and Ranjan et al. (30) reported that adding magnesium to levobupivacaine resulted in no significant differences in the onset of motor block and the length of sensory and motor block.
Similar to our results, Rekha et al. (31) evaluated orthopedic procedures, and found that adding 50 mg of magnesium to epidural ropivacaine shortened the onset of sensory and motor block while it had no effects on the duration of sensory block and no significant adverse effects.
Other studies used different doses of magnesium as an adjuvant to opioids and/or LAs of different types, and they reported results similar to our study. Elsharkawy et al. (23), in preeclampsia patients receiving elective CS, added 500 mg of magnesium to spinal bupivacaine. Gupta et al. (32) utilized 500 mg of magnesium as an adjuvant to epidural ropivacaine and fentanyl in labor analgesia. Radwan et al. (33), in old patients undergoing spine operations, compared 50 mg of magnesium to fentanyl as an adjuvant to epidural levobupivacaine with continuous infusion intraoperatively. All these studies found that adding magnesium to the mix accelerated the onset of motor and sensory block and lengthened the block’s duration. Despite using different doses of magnesium, there were no maternal, neonatal, or geriatric adverse outcome.
Some clinical trials compared magnesium with other adjuvants to EA. Hanoura et al. (34) evaluated adding dexmedetomidine to EA in CS; there were no variations in the block onset or the duration of the block, but the duration of sensory block was prolonged and there were no maternal or fetal adverse consequences. Also, Shahi et al. (35), in orthopedic surgeries, compared magnesium and dexmedetomidine as an adjuvant to EA. They found that shorter time to achieve sensory block was obtained by adding dexmedetomidine (but it was not statistically significant), while there was prolongation of sensory and motor block. The delayed motor recovery may be inappropriate for postpartum females who are in need for early ambulation and care of the baby. There was also a significant variation in the incidence of bradycardia (not hypotension). So, due to bradycardia and the potential risk of hypotension, the benefit-risk ratio must be balanced when dexmedetomidine is added to EA in CS. Meanwhile, epidural magnesium seems to be a good alternative to dexmedetomidine.
In contrast to these findings, Hanoura et al. (36) showed that neither the onset of the block nor the recovery of the motor block were affected by epidural dexmedetomidine in CS. However, it prolonged the sensory block, enhanced the quality of intraoperative and postoperative analgesia, while maintaining a low degree of arousal sedation without causing major maternal or neonatal side effects. Also, Imani et al. (37) demonstrated that combination of intravenous dexmedetomidine with non-opioid analgesics for pain management in CS did not have hemodynamic complications.
In lower limb and abdominal procedures, compared to epidural clonidine (22), epidural magnesium allows for a rapid onset of surgical anesthesia with no side effects, while adding clonidine prolongs anesthesia duration along with significant sedation. Similar results were obtained by Bajwa et al. (38), as they found that epidural clonidine in CS resulted in shorter onset of analgesia with a longer duration, but with more bradycardia and hypotension occurrence, which may be detrimental for parturients. Rajabi et al. (39) reported that when intravenous infusion of magnesium or clonidine were used in combination with GA in CS, once at the time of the induction, they had favorable hemodynamic and anesthetic profile with no risk to the neonate.
This study had some limitations. First, different doses of MgSO4 should be used to know the optimum dose to be used without significant side effects. Second, the synergistic effect of intravenous and epidural MgSO4 should be studied, which may speed up the onset of action.
5.1. Conclusions
To conclude, adding 50 mg of MgSO4 to levobupivacaine in the epidural catheter during the epidural labor analgesia to anesthesia conversion for an emergency CS significantly accelerated the onset of sensory block and delayed the recovery of both sensory and motor block, without any major maternal or fetal side effects.
References
-
1.
Manouchehrian N, Rabiei S, Moradi A, Lakpur Z. Comparison of Intrathecal Injection of Fentanyl and Sufentanil on the Onset, Duration, and Quality of Analgesia in Labor: A Randomized, Double-Blind Clinical Trial. Anesth Pain Med. 2020;10(3). e99843. [PubMed ID: 32944556]. [PubMed Central ID: PMC7472646]. https://doi.org/10.5812/aapm.99843.
-
2.
Rahmati J, Shahriari M, Shahriari A, Nataj M, Shabani Z, Moodi V. Effectiveness of Spinal Analgesia for Labor Pain Compared with Epidural Analgesia. Anesth Pain Med. 2021;11(2). e113350. [PubMed ID: 34336624]. [PubMed Central ID: PMC8314089]. https://doi.org/10.5812/aapm.113350.
-
3.
Chandra S, Nugroho AM, Agus H, Susilo AP. How Low Can We Go? A Double-Blinded Randomized Controlled Trial to Compare Bupivacaine 5 mg and Bupivacaine 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population. Anesth Pain Med. 2019;9(2). e91275. [PubMed ID: 31341830]. [PubMed Central ID: PMC6615063]. https://doi.org/10.5812/aapm.91275.
-
4.
Imani F, Farahmand Rad R, Salehi R, Alimian M, Mirbolook Jalali Z, Mansouri A, et al. Evaluation of Adding Dexmedetomidine to Ropivacaine in Pediatric Caudal Epidural Block: A Randomized, Double-blinded Clinical Trial. Anesth Pain Med. 2021;11(1). [PubMed ID: 34221950]. [PubMed Central ID: PMC8241816]. https://doi.org/10.5812/aapm.112880.
-
5.
Desai N, Gardner A, Carvalho B. Labor Epidural Analgesia to Cesarean Section Anesthetic Conversion Failure: A National Survey. Anesthesiol Res Pract. 2019;2019:6381792. [PubMed ID: 31281354]. [PubMed Central ID: PMC6589285]. https://doi.org/10.1155/2019/6381792.
-
6.
Kim H, Shin SH, Ko MJ, Park YH, Lee KH, Kim KH, et al. Correlation Between Anthropometric Measurements and Sensory Block Level of Spinal Anesthesia for Cesarean Section. Anesth Pain Med. 2021;11(5). e118627. [PubMed ID: 35075414]. [PubMed Central ID: PMC8782058]. https://doi.org/10.5812/aapm.118627.
-
7.
Regan KJ, O'Sullivan G. The extension of epidural blockade for emergency Caesarean section: a survey of current UK practice. Anaesthesia. 2008;63(2):136-42. [PubMed ID: 18211443]. https://doi.org/10.1111/j.1365-2044.2007.05319.x.
-
8.
Hillyard SG, Bate TE, Corcoran TB, Paech MJ, O'Sullivan G. Extending epidural analgesia for emergency Caesarean section: a meta-analysis. Br J Anaesth. 2011;107(5):668-78. [PubMed ID: 21997149]. https://doi.org/10.1093/bja/aer300.
-
9.
Olapour A, Akhondzadeh R, Rashidi M, Gousheh M, Homayoon R. Comparing the Effect of Bupivacaine and Ropivacaine in Cesarean Delivery with Spinal Anesthesia. Anesth Pain Med. 2020;10(1). e94155. [PubMed ID: 32337166]. [PubMed Central ID: PMC7144247]. https://doi.org/10.5812/aapm.94155.
-
10.
Sng BL, Pay LL, Sia AT. Comparison of 2% lignocaine with adrenaline and fentanyl, 0.75% ropivacaine and 0.5% levobupivacaine for extension of epidural analgesia for urgent caesarean section after low dose epidural infusion during labour. Anaesth Intensive Care. 2008;36(5):659-64. [PubMed ID: 18853583]. https://doi.org/10.1177/0310057X0803600505.
-
11.
Urits I, Jung JW, Amgalan A, Fortier L, Anya A, Wesp B, et al. Utilization of Magnesium for the Treatment of Chronic Pain. Anesth Pain Med. 2021;11(1). e112348. [PubMed ID: 34221945]. [PubMed Central ID: PMC8236839]. https://doi.org/10.5812/aapm.112348.
-
12.
Imani F, Rahimzadeh P, Faiz HR, Abdullahzadeh-Baghaei A. An Evaluation of the Adding Magnesium Sulfate to Ropivacaine on Ultrasound-Guided Transverse Abdominis Plane Block After Abdominal Hysterectomy. Anesth Pain Med. 2018;8(4). e74124. [PubMed ID: 30250819]. [PubMed Central ID: PMC6139531]. https://doi.org/10.5812/aapm.74124.
-
13.
Rashwan DAEK, Mohammed AR, Kasem Rashwan SA, Abd El Basset AS, Nafady HA. Efficacy of Serratus Anterior Plane Block Using Bupivacaine/ Magnesium Sulfate Versus Bupivacaine/ Nalbuphine for Mastectomy: A Randomized, Double-Blinded Comparative Study. Anesth Pain Med. 2020;10(3). e103141. [PubMed ID: 32944562]. [PubMed Central ID: PMC7472790]. https://doi.org/10.5812/aapm.103141.
-
14.
Faiz SH, Rahimzadeh P, Imani F, Bakhtiari A. Intrathecal injection of magnesium sulfate: shivering prevention during cesarean section: a randomized, double-blinded, controlled study. Korean J Anesthesiol. 2013;65(4):293-8. [PubMed ID: 24228140]. [PubMed Central ID: PMC3822019]. https://doi.org/10.4097/kjae.2013.65.4.293.
-
15.
Yousef AA, Amr YM. The effect of adding magnesium sulphate to epidural bupivacaine and fentanyl in elective caesarean section using combined spinal-epidural anaesthesia: a prospective double blind randomised study. Int J Obstet Anesth. 2010;19(4):401-4. [PubMed ID: 20833531]. https://doi.org/10.1016/j.ijoa.2010.07.019.
-
16.
Hasanein R, El-sayed W, Khalil M. The value of epidural magnesium sulfate as an adjuvant to bupivacaine and fentanyl for labor analgesia. Egyp J Anaesth. 2019;29(3):219-24. https://doi.org/10.1016/j.egja.2013.02.002.
-
17.
Nugroho AM, Sugiarto A, Chandra S, Lembahmanah L, Septica RI, Yuneva A. A Comparative Study of Fractionated Versus Single Dose Injection for Spinal Anesthesia During Cesarean Section in Patients with Pregnancy-Induced Hypertension. Anesth Pain Med. 2019;9(1). e85115. [PubMed ID: 30881909]. [PubMed Central ID: PMC6413406]. https://doi.org/10.5812/aapm-85115.
-
18.
Shafeinia A, Ghaed MA, Nikoubakht N. The Effect of Phenylephrine Infusion on Maternal Hemodynamic Changes During Spinal Anesthesia for Cesarean Delivery. Anesth Pain Med. 2020;10(1). e99094. [PubMed ID: 32309198]. [PubMed Central ID: PMC7144416]. https://doi.org/10.5812/aapm.99094.
-
19.
Nikooseresht M, Seifrabiei MA, Hajian P, Khamooshi S. A Clinical Trial on the Effects of Different Regimens of Phenylephrine on Maternal Hemodynamic After Spinal Anesthesia for Cesarean Section. Anesth Pain Med. 2020;10(4). e58048. [PubMed ID: 33134140]. [PubMed Central ID: PMC7539049]. https://doi.org/10.5812/aapm.58048.
-
20.
Javaherforooshzadeh F, Pipelzadeh MR, Akhondzadeh R, Adarvishi S, Alghozat M. Effect of Sequential Compression Device on Hemodynamic Changes After Spinal Anesthesia for Caesarean Section: A Randomized Controlled Trial. Anesth Pain Med. 2020;10(5). e104705. [PubMed ID: 34150562]. [PubMed Central ID: PMC8207840]. https://doi.org/10.5812/aapm.104705.
-
21.
Balaji P, Dhillon P, Russell IF. Low-dose epidural top up for emergency caesarean delivery: a randomised comparison of levobupivacaine versus lidocaine/epinephrine/fentanyl. Int J Obstet Anesth. 2009;18(4):335-41. [PubMed ID: 19733053]. https://doi.org/10.1016/j.ijoa.2009.03.011.
-
22.
Ghatak T, Chandra G, Malik A, Singh D, Bhatia VK. Evaluation of the effect of magnesium sulphate vs. clonidine as adjunct to epidural bupivacaine. Indian J Anaesth. 2010;54(4):308-13. [PubMed ID: 20882172]. [PubMed Central ID: PMC2943699]. https://doi.org/10.4103/0019-5049.68373.
-
23.
Elsharkawy RA, Farahat TE, Abdelhafez MS. Analgesic effect of adding magnesium sulfate to epidural levobupivacaine in patients with pre-eclampsia undergoing elective cesarean section. J Anaesthesiol Clin Pharmacol. 2018;34(3):328-34. [PubMed ID: 30386015]. [PubMed Central ID: PMC6194846]. https://doi.org/10.4103/joacp.JOACP_1_18.
-
24.
Ko SH, Lim HR, Kim DC, Han YJ, Choe H, Song HS. Magnesium sulfate does not reduce postoperative analgesic requirements. Anesthesiology. 2001;95(3):640-6. [PubMed ID: 11575536]. https://doi.org/10.1097/00000542-200109000-00016.
-
25.
Sun J, Wu X, Xu X, Jin L, Han N, Zhou R. A comparison of epidural magnesium and/or morphine with bupivacaine for postoperative analgesia after cesarean section. Int J Obstet Anesth. 2012;21(4):310-6. [PubMed ID: 22858044]. https://doi.org/10.1016/j.ijoa.2012.05.006.
-
26.
Lysakowski C, Dumont L, Czarnetzki C, Tramer MR. Magnesium as an adjuvant to postoperative analgesia: a systematic review of randomized trials. Anesth Analg. 2007;104(6):1532-9. [PubMed ID: 17513654]. https://doi.org/10.1213/01.ane.0000261250.59984.cd.
-
27.
Omar H. Magnesium Sulfate as a Preemptive Adjuvant to Levobupivacaine for Postoperative Analgesia in Lower Abdominal and Pelvic Surgeries under Epidural Anesthesia(Randomized Controlled Trial). Anesth Essays Res. 2018;12(1):256-61. [PubMed ID: 29628592]. [PubMed Central ID: PMC5872875]. https://doi.org/10.4103/aer.AER_194_17.
-
28.
Seyam S, Elsheshtawy K, Morsy M. The Effect of Epidural Magnesium Sulfate as An Adjuvant to Fentanyl for Postoperative Analgesia after Lower Limb Orthopedic Surgery. Al-Azhar Int Med J. 2020;1(1):103-10. https://doi.org/10.21608/aimj.2020.21488.1033.
-
29.
Ahmed OH, Ali WM, Kamel YM. Magnesium Sulfate versus Fentanyl as Adjuvant to Epidural Levobupivacaine in Surgeries below Umbilicus. Egypt J Hosp Med. 2019;77(2):4987-92. https://doi.org/10.21608/ejhm.2019.48134.
-
30.
Ranjan DR, Pradhan DRK, Singh DP, Kokne DM. A comparative study of epidural bupivacaine and epidural bupivacaine with magnesium sulphate for perioperative analgesia in patients undergoing lower limb surgery. Int J Med Anestheol. 2019;2(2):31-5. https://doi.org/10.33545/26643766.2019.v2.i2a.26.
-
31.
Rekha PAL, Chakravarthy K, Das PK, Vaddi P. A Comparative Study Between Epidural Plain Ropivacaine and Ropivacaine With Magnesium Sulfate for Elective Lower Limb Surgeries. J Med Sci Clin Res. 2020;8(11):267-72. https://doi.org/10.18535/jmscr/v8i11.47.
-
32.
Gupta M, Kumari I, Sharma S, Aggarwal A. Evaluation of the efficacy of MgSO4 as an adjunct to ropivacaine and fentanyl for labour analgesia. J Obstet Anaesth Critical Care. 2020;10(1). https://doi.org/10.4103/joacc.JOACC_54_19.
-
33.
Radwan T, Awad M, Fahmy R, El Emady M, Arafa M. Evaluation of analgesia by epidural magnesium sulphate versus fentanyl as adjuvant to levobupivacaine in geriatric spine surgeries. Randomized controlled study. Egypt J Anaesth. 2019;33(4):357-63. https://doi.org/10.1016/j.egja.2017.07.003.
-
34.
Hanoura SE, Saad RH, Singh R. Dexmedetomidine improves intraoperative conditions and quality of postoperative analgesia when added to epidural in elective cesarean section. Egypt J Anaesth. 2019;30(4):353-7. https://doi.org/10.1016/j.egja.2014.03.004.
-
35.
Shahi V, Verma AK, Agarwal A, Singh CS. A comparative study of magnesium sulfate vs dexmedetomidine as an adjunct to epidural bupivacaine. J Anaesthesiol Clin Pharmacol. 2014;30(4):538-42. [PubMed ID: 25425781]. [PubMed Central ID: PMC4234792]. https://doi.org/10.4103/0970-9185.142852.
-
36.
Hanoura SE, Hassanin R, Singh R. Intraoperative conditions and quality of postoperative analgesia after adding dexmedetomidine to epidural bupivacaine and fentanyl in elective cesarean section using combined spinal-epidural anesthesia. Anesth Essays Res. 2013;7(2):168-72. [PubMed ID: 25885827]. [PubMed Central ID: PMC4173533]. https://doi.org/10.4103/0259-1162.118947.
-
37.
Imani F, Rahimzadeh P, Faiz HR, Nowruzina S, Shakeri A, Ghahremani M. Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial. Anesth Pain Med. 2018;8(5). e85311. [PubMed ID: 30538943]. [PubMed Central ID: PMC6252045]. https://doi.org/10.5812/aapm.85311.
-
38.
Bajwa SJ, Bajwa SK, Kaur J. Comparison of epidural ropivacaine and ropivacaine clonidine combination for elective cesarean sections. Saudi J Anaesth. 2010;4(2):47-54. [PubMed ID: 20927262]. [PubMed Central ID: PMC2945514]. https://doi.org/10.4103/1658-354X.65119.
-
39.
Rajabi M, Razavizade MR, Hamidi-Shad M, Tabasi Z, Akbari H, Hajian A. Magnesium Sulfate and Clonidine; Effects on Hemodynamic Factors and Depth of General Anesthesia in Cesarean Section. Anesth Pain Med. 2020;10(5). e100563. [PubMed ID: 34150557]. [PubMed Central ID: PMC8207846]. https://doi.org/10.5812/aapm.100563.